Details of the Drug

General Information of Drug (ID: DM96AKV)

Drug Name
PF-06747775
Synonyms mavelertinib; JYIUNVOCEFIUIU-RRKGBCIJSA-N; PF06747775; SCHEMBL20274518; BCP17532
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Phase 1 [1]
Structure
3D MOL 2D MOL
Chemical Identifiers
Formula
C18H22FN9O2
Canonical SMILES
CN1C=C(C(=N1)OC)NC2=C3C(=NC(=N2)N4CC(C(C4)F)NC(=O)C=C)N(C=N3)C
InChI
InChI=1S/C18H22FN9O2/c1-5-13(29)21-11-8-28(6-10(11)19)18-23-15(14-16(24-18)26(2)9-20-14)22-12-7-27(3)25-17(12)30-4/h5,7,9-11H,1,6,8H2,2-4H3,(H,21,29)(H,22,23,24)/t10-,11-/m1/s1
InChIKey
JYIUNVOCEFIUIU-GHMZBOCLSA-N
Cross-matching ID
PubChem CID
91668194
ChEBI ID
CHEMBL3989970
CAS Number
1776112-90-3
UNII
YXX2180047
DrugBank ID
DB16228
TTD ID
D0R0LB
Drug-Molecule Activity Atlas (DMA)NEW Click to Jump to the Detailed DMA Information of This Drug
Drug ADMET Endpoint Profile (DAE)NEW Click to Jump to the Detailed DAE Information of This Drug
Combinatorial Drugs (CBD) Click to Jump to the Detailed CBD Information of This Drug

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)